Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cook County Health
To conduct a prospective observational study in 60 patients with newly diagnosed Graves' disease who are either methimazole naive or who have been initiated on MMI within previous 4-6 weeks per CCH algorithm and assess for efficacy and safety of MMI dosing administered. Study group size is based on 90% power and projected efficacy of 70% patients reaching target.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Non-pregnant adults (\>18 years of age) with new diagnosis of Graves' Disease (elevated free T4, Free T3, low or suppressed TSH, positive TSI and or thyroid eye disease) and
either drug naïve or who have been initiated on MMI within previous 4-6 weeks per CCH algorithm.
You may not be if
Pregnant patients
hyperthyroidism due to other causes, example - Toxic Multinodular Goiter, Iodine induced thyrotoxicosis, etc.
Graves patients who present with atrial fibrillation, CHF or other end organ damage
